Exelixis, Inc. is engaged in the discovery and validation of novel targets for several major human diseases, and is also engaged in the discovery of potential new drug therapies, specifically for cancer and other proliferative diseases. The Company's primary mission is to develop proprietary human therapeutics by leveraging its integrated discovery platform to increase the speed, efficiency and quality of pharmaceutical product discovery and development.
 

170 Harbor Way, P.O. Box 511
South San Francisco, CA 94083
Phone: (650) 837-7000
Fax: (650) 825-2205